Press Releases about Roivant Sciences Ltd WT![]() ![]() ![]() ![]() ![]() ![]()
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]()
Roivant Announces Completion of Redemption of its Outstanding Warrants
September 11, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]()
Roivant Announces Redemption of Outstanding Warrants
August 02, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|